At a glance
- Originator Servier
- Class Analgesics; Anti-inflammatories; Dipeptides
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain; Respiratory tract disorders
Most Recent Events
- 03 Nov 2003 No development reported - Preclinical for Inflammation in France (unspecified route)
- 03 Nov 2003 No development reported - Preclinical for Respiratory tract disorders in France (unspecified route)
- 02 Sep 1998 No-Development-Reported for Pain in France (Unknown route)